期刊文献+

微小RNA在脓毒症中免疫调控的研究进展 被引量:4

Advances of microRNA immunoregulation in sepsis
原文传递
导出
摘要 微小RNA是一类内源性非编码的小分子RNA。近年来研究证实微小RNA广泛参与和调控机体固有免疫与适应性免疫的各个环节。在脓毒症过程中,紊乱的固有免疫与适应性免疫均参与发病。 MicroRNA is a kind of endogenous non-coding of small molecules RNA. It has been conf'trrned that the microRNA play a role in innate immunity and adaptive immunity which are involved in sepsis.
出处 《国际儿科学杂志》 2012年第1期49-53,共5页 International Journal of Pediatrics
基金 深圳市科技计划项目(医疗卫生类)立项非资助项目(201103140)
关键词 微小RNA 脓毒症 免疫调控 MicroRNA Sepsis Immune regulation
作者简介 通信作者:李成荣,Email:rogasan@163.com
  • 相关文献

参考文献4

二级参考文献55

  • 1樊寻梅.儿科感染性休克(脓毒性休克)诊疗推荐方案[J].中华儿科杂志,2006,44(8):596-598. 被引量:205
  • 2中华医学会儿科学会急救学组.小儿危重病例评分法(草案)[J].中华儿科杂志,1995,33(6):371-371.
  • 3American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference : definitions for sepsis and multiple organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med, 1992,20(6) :864-874.
  • 4Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/ SIS International Sepsis Definitions Conference. Crit Care Med, 2003,31 (4) : 1250-1256.
  • 5Sands KE, Bates DW, Lanken PN, et al. Epidemiology of sepsis syndrome in 8 academic medical centers. JAMA, 1997,278 (3) : 234-240.
  • 6Goldstein B, Giroir B, Randolph A, et al. Pediatric sepsis consensus Conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med,2005,6(1) :2-8.
  • 7Duffy MJ. Clinical uses of tumor markers: a critical review. Crit Rev Clin Lab Sci 2001; 38:225-262.
  • 8Thomas CM, Sweep CG. Serum tumor markers: past, state of the art, and future, lnt J Biol Markers 2001; 16:73-86.
  • 9Duffy MJ. Role of tumor markers in patients with solid cancers: a critical review. Eur J lntern Med 2007; 18:175-184.
  • 10Roulston JE. Limitations of tumour markers in screening. Br J Surg 1990; 77:961-962.

共引文献1008

同被引文献76

  • 1樊寻梅.儿科感染性休克(脓毒性休克)诊疗推荐方案[J].中华儿科杂志,2006,44(8):596-598. 被引量:205
  • 2Cortez MA,Calin GA. MicroRNA identification in plasma and serum:a new tool to diagnose and monitor diseases[J].Expert Opinion on Biological Therapy,2009,(06):703-711.
  • 3Dellinger RP,Levy MM,Rhodes A. Surviving sepsis campaign:international guidelines for management of severe sepsis and septic shock,2012[J].Intensive Care Medicine,2013,(02):165-228.
  • 4Dombrovskiy VY,Martin AA,Sunderram J. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States:a trend analysis from 1993 to 2003[J].Critical Care Medicine,2007,(05):1244-1250.doi:10.1097/01.CCM.0000261890.41311.E9.
  • 5Ivády B,Béres BJ,Szab6 D. Recent advances in sepsis research:novel biomarkers and therapeutic targets[J].Current Medicinal Chemistry,2011,(21):3211-3225.
  • 6O'Neill LA,Sheedy FJ,McCoy CE. MicroRNAs:the fine-tuners of Tolllike receptor signalling[J].Nature Reviews Immunology,2011,(03):163-175.
  • 7Schmidt WM,Spiel AO,Jilma B. In vivo profile of the human leukocyte microRNA response to endotoxemia[J].Biochemical and Biophysical Research Communications,2009,(03):437-441.doi:10.1016/j.bbrc.2008.12.190.
  • 8Reid G,Kirschner MB,van Zandwijk N. Circulating microRNAs:association with disease and potential use as biomarkers[J].Critical Reviews in Oncology/Hematology,2011,(02):193-208.
  • 9Wang JF,Yu ML,Yu G. Serum miR-146a and miR-223 as potential new biomarkers for sepsis[J].Biochemical and Biophysical Research Communications,2010,(01):184-188.
  • 10Vasilescu C,Rossi S,Shimizu M. MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis[J].PLoS One,2009,(10):e7405.

引证文献4

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部